Avantor Common Stock Net 2018-2025 | AVTR
- Avantor common stock net for the quarter ending March 31, 2025 was $3.948B, a 1.73% increase year-over-year.
- Avantor common stock net for 2024 was $3.938B, a 2.81% increase from 2023.
- Avantor common stock net for 2023 was $3.83B, a 1.18% increase from 2022.
- Avantor common stock net for 2022 was $3.785B, a 37.52% increase from 2021.
Avantor Annual Common Stock Net (Millions of US $) |
|
---|---|
2024 | $3,938 |
2023 | $3,830 |
2022 | $3,785 |
2021 | $2,753 |
2020 | $1,738 |
2019 | $1,748 |
2018 | $-2,747 |
2017 | $0 |
Avantor Quarterly Common Stock Net (Millions of US $) |
|
---|---|
2025-03-31 | $3,948 |
2024-12-31 | $3,938 |
2024-09-30 | $3,925 |
2024-06-30 | $3,898 |
2024-03-31 | $3,881 |
2023-12-31 | $3,830 |
2023-09-30 | $3,818 |
2023-06-30 | $3,799 |
2023-03-31 | $3,792 |
2022-12-31 | $3,785 |
2022-09-30 | $3,775 |
2022-06-30 | $3,756 |
2022-03-31 | $2,749 |
2021-12-31 | $2,753 |
2021-09-30 | $2,749 |
2021-06-30 | $1,748 |
2021-03-31 | $1,743 |
2020-12-31 | $1,738 |
2020-09-30 | $1,744 |
2020-06-30 | $1,744 |
2020-03-31 | $1,748 |
2019-12-31 | $1,748 |
2019-09-30 | $1,754 |
2019-06-30 | $1,768 |
2019-03-31 | $0 |
2018-12-31 | |
2018-09-30 | $0 |
2018-06-30 | $0 |
2017-12-31 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $7.935B | $6.784B |
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $142.523B | 26.43 |
CVS Health (CVS) | United States | $80.437B | 10.00 |
Elevance Health (ELV) | United States | $62.242B | 8.37 |
Cencora (COR) | United States | $56.664B | 19.71 |
DiDi Global (DIDIY) | China | $24.380B | 25.90 |
Labcorp Holdings (LH) | United States | $21.895B | 17.40 |
Natera (NTRA) | United States | $19.133B | 0.00 |
BioMerieux (BMXMF) | France | $17.067B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $15.105B | 0.00 |
ICON (ICLR) | Ireland | $13.404B | 12.90 |
CochLear (CHEOY) | Australia | $13.242B | 0.00 |
Solventum (SOLV) | United States | $12.531B | 13.27 |
Medpace Holdings (MEDP) | United States | $12.257B | 32.44 |
Viatris (VTRS) | United States | $10.540B | 3.62 |
Revvity (RVTY) | United States | $10.453B | 18.14 |
Sonic Healthcare (SKHHY) | Australia | $8.877B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.226B | 16.12 |
HealthEquity (HQY) | United States | $7.870B | 34.47 |
Caris Life Sciences,�Inc (CAI) | United States | $7.708B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $5.109B | 34.38 |
Amplifon S.p.A (AMFPF) | Italy | $3.890B | 21.30 |
BrightSpring Health Services (BTSG) | United States | $3.516B | 26.82 |
Sotera Health (SHC) | United States | $3.176B | 18.05 |
GeneDx Holdings (WGS) | United States | $3.043B | 70.16 |
Surgery Partners (SGRY) | United States | $2.837B | 35.71 |
Alignment Healthcare (ALHC) | United States | $2.656B | 0.00 |
Concentras Parent (CON) | United States | $2.540B | 14.68 |
Organon (OGN) | United States | $2.184B | 2.38 |
Progyny (PGNY) | United States | $1.990B | 43.81 |
Premier (PINC) | United States | $1.788B | 13.57 |
PACS (PACS) | United States | $1.740B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.568B | 31.36 |
Ardent Health (ARDT) | United States | $1.523B | 5.88 |
Establishment Labs Holdings (ESTA) | $1.273B | 0.00 | |
Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
Pediatrix Medical (MD) | United States | $1.110B | 7.51 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.831B | 285.00 |
CareDx (CDNA) | United States | $0.715B | 11.17 |
AMN Healthcare Services Inc (AMN) | United States | $0.670B | 6.27 |
Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
Embecta (EMBC) | United States | $0.580B | 3.91 |
LifeMD (LFMD) | United States | $0.538B | 0.00 |
Nutex Health (NUTX) | United States | $0.506B | 7.67 |
So-Young (SY) | China | $0.499B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.466B | 10.50 |
InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
SBC Medicals (SBC) | United States | $0.453B | 0.00 |
Omada Health (OMDA) | $0.446B | 0.00 | |
COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
Agilon Health (AGL) | United States | $0.365B | 0.00 |
Oncology Institute (TOI) | United States | $0.353B | 0.00 |
Enhabit (EHAB) | United States | $0.339B | 27.88 |
Beauty Health (SKIN) | United States | $0.208B | 0.00 |
DocGo (DCGO) | United States | $0.143B | 23.33 |
Ascend Wellness Holdings (AAWH) | United States | $0.094B | 0.00 |
Sera Prognostics (SERA) | United States | $0.092B | 0.00 |
Biodesix (BDSX) | United States | $0.062B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
KindlyMD (NAKA) | United States | $0.053B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
ModivCare (MODV) | United States | $0.037B | 0.00 |
OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |